Refractory Cutaneous T-cell Lymphoma
1 clinical trials · Condition
◉ Watch Refractory Cutaneous T-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL) (NCT01007448) | Bausch Health Americas, Inc. | 2010-01-06 |
Track Refractory Cutaneous T-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.